"Methylnaltrexone, which is approved for the treatment of opioid-related constipation, appears to extend survival in people receiving opioids for advanced cancer pain, according to new research.
Increasing evidence indicates that treat"...
- Advise patients of the following expected adverse events: headache, nausea, vomiting, and fever, and about the early signs and symptoms of neurotoxicity.
- Advise patients of the importance of concurrent dexamethasone administration should be emphasized at the initiation of each cycle of DepoCyt® treatment.
- Instruct patients to seek medical attention if signs or symptoms of neurotoxicity develop, or if oral dexamethasone is not well tolerated.
Last reviewed on RxList: 2/16/2016
This monograph has been modified to include the generic and brand name in many instances.
Additional DepoCyt Information
DepoCyt - User Reviews
DepoCyt User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Get the latest treatment options.